|
|
Volumn 17, Issue 4, 2009, Pages 405-411
|
|
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings
a
b
c
|
|
Author keywords
Chemotherapy; Emesis CINV; Importance; Supportive care
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
APREPITANT;
BEVACIZUMAB;
CAPECITABINE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DEXAMETHASONE;
DOXORUBICIN;
NAVELBINE;
ONDANSETRON;
PACLITAXEL;
PROCHLORPERAZINE;
ADULT;
AGED;
ANTIEMETIC ACTIVITY;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CASE REPORT;
CHEMOTHERAPY INDUCED EMESIS;
DRUG CHOICE;
EUROPE;
FEMALE;
FRANCE;
GERMANY;
HEALTH SURVEY;
HUMAN;
INTRADUCTAL CARCINOMA;
ITALY;
LUNG SQUAMOUS CELL CARCINOMA;
MALE;
PHYSICIAN ATTITUDE;
PRESCRIPTION;
PRIORITY JOURNAL;
UNITED KINGDOM;
UNITED STATES;
AGE FACTORS;
AGED;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
DATA COLLECTION;
EUROPE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
PHYSICIAN'S PRACTICE PATTERNS;
PHYSICIANS;
PROGNOSIS;
UNITED STATES;
|
|
EID: 62449147059
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s00520-008-0501-6 Document Type: Article |
|
Times cited : (12)
|
|
References (12)
|
